Literature DB >> 21030885

Timing of correct parenteral antibiotic initiation and outcomes from severe bacterial community-acquired pneumonia in children.

Jennifer A Muszynski1, Nina L Knatz, Cheryl L Sargel, Soledad A Fernandez, David J Marquardt, Mark W Hall.   

Abstract

BACKGROUND: The impact of timing of appropriate antibiotic initiation for critically ill children with severe bacterial community-acquired pneumonia (CAP) is unknown. We hypothesized that longer time to initiation of correct parenteral antibiotic would be associated with longer durations of mechanical ventilation, intensive care unit length of stay, and hospital length of stay.
METHODS: We retrospectively reviewed medical records of children admitted to Nationwide Children's Hospital between January 2004 and December 2006 with bacterial CAP treated with mechanical ventilation, excluding those with documented viral infection. Time to correct antibiotic was defined as time from presentation to any emergency department to the initiation of a parenteral antibiotic to which cultured pathogens were susceptible.
RESULTS: In all, 45 patients, median age 17 months, were identified. Median time to correct antibiotic was 10.3 hours, with 71% of patients receiving correct empiric therapy. After adjusting for severity of illness, longer time to correct antibiotic was independently associated with longer hospital stay (P = 0.007). For the 23 patients in the cohort for whom pneumonia was the primary diagnosis, longer time to correct antibiotic was independently associated with longer durations of mechanical ventilation (P = 0.01), intensive care unit stay (P = 0.001), and hospital stay (P = 0.006). Delays in antibiotic administration as short as 2 to 4 hours were associated with adverse outcomes in this group.
CONCLUSIONS: In our critically ill children with severe bacterial CAP, longer delays in receipt of appropriate empiric antibiotics were independently associated with adverse outcomes.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21030885     DOI: 10.1097/INF.0b013e3181ff64ec

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  15 in total

1.  Population Pharmacokinetics and Pharmacodynamic Target Attainment of Meropenem in Critically Ill Young Children.

Authors:  Jeffrey J Cies; Wayne S Moore; Adela Enache; Arun Chopra
Journal:  J Pediatr Pharmacol Ther       Date:  2017 Jul-Aug

2.  Therapeutic Drug Monitoring of Prolonged Infusion Aztreonam for Multi-Drug Resistant Pseudomonas aeruginosa: A Case Report.

Authors:  Jeffrey J Cies; Richard J LaCoursiere; Wayne S Moore; Arun Chopra
Journal:  J Pediatr Pharmacol Ther       Date:  2017 Nov-Dec

3.  Therapeutic Drug Monitoring of Continuous Infusion Doripenem in a Pediatric Patient on Continuous Renal Replacement Therapy.

Authors:  Jeffrey J Cies; Wayne S Moore; Susan B Conley; Paul Shea; Adela Enache; Arun Chopra
Journal:  J Pediatr Pharmacol Ther       Date:  2017 Jan-Feb

4.  Treatment failure among Kenyan children with severe pneumonia--a cohort study.

Authors:  Clare Webb; Mwanajuma Ngama; Anthony Ngatia; Mohammed Shebbe; Susan Morpeth; Salim Mwarumba; Ann Bett; D James Nokes; Anna C Seale; Sidi Kazungu; Patrick Munywoki; Laura L Hammitt; J Anthony G Scott; James A Berkley
Journal:  Pediatr Infect Dis J       Date:  2012-09       Impact factor: 2.129

Review 5.  Pediatric sepsis: challenges and adjunctive therapies.

Authors:  William Hanna; Hector R Wong
Journal:  Crit Care Clin       Date:  2013-01-03       Impact factor: 3.598

6.  Pharmacokinetics of Continuous Infusion Meropenem With Concurrent Extracorporeal Life Support and Continuous Renal Replacement Therapy: A Case Report.

Authors:  Jeffrey J Cies; Wayne S Moore; Susan B Conley; Mindy J Dickerman; Christine Small; Dominick Carella; Paul Shea; Jason Parker; Arun Chopra
Journal:  J Pediatr Pharmacol Ther       Date:  2016 Jan-Feb

7.  Time to initiation of antifungal therapy for neonatal candidiasis.

Authors:  Jennifer Le; Tu T Tran; Ivilynn Bui; Mike K Wang; Andrew Vo; Felice C Adler-Shohet
Journal:  Antimicrob Agents Chemother       Date:  2013-03-18       Impact factor: 5.191

8.  Variability in pediatric infectious disease consultants' recommendations for management of community-acquired pneumonia.

Authors:  Adam L Hersh; Daniel J Shapiro; Jason G Newland; Philip M Polgreen; Susan E Beekmann; Samir S Shah
Journal:  PLoS One       Date:  2011-05-31       Impact factor: 3.240

9.  Evaluation of Drug Treatment of Bronchopneumonia at the Pediatric Clinic in Sarajevo.

Authors:  Svjetlana Loga Zec; Kenan Selmanovic; Natasa Loga Andrijic; Azra Kadic; Lamija Zecevic; Lejla Zunic
Journal:  Med Arch       Date:  2016-05-31

10.  Emergency department crowding and time to antibiotic administration in febrile infants.

Authors:  Jennifer K Light; Robyn M Hoelle; Jill Boylston Herndon; Wei Hou; Marie-Carmelle Elie; Kelly Jackman; J Adrian Tyndall; Donna L Carden
Journal:  West J Emerg Med       Date:  2013-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.